Skip to main content

Table 2 Clinical characteristics, outcomes, and secondary prevention at discharge

From: Stroke in a resource-constrained hospital in Madagascar

Entire cohort n = 30
Mobilization out of bed
 Yes 15 (50%)
 No 15 (50%)
Complications
 Stroke progression 11 (37%)
 Chest infection 5 (17%)
 Bedsores 2 (7%)
 Seizures 1 (3%)
 Urinary tract infection 0
 No 14 (47%)
In-hospital stroke mortality 9 (30%)
Disability (mRS score)
 Mild (mRS 0–2) 1 (3%)
 Moderate (mRS 3) 3 (10%)
 Severe (mRS 4–5) 17 (57%)
 Dead (mRS 6) 9 (30%)
Survivors n = 21
Swallowing function
 Normal 13 (62%)
 Impaired 0
 Not testable 8 (38%)
Blood pressure (mmHg)
 Low (<100/60) 1 (5%)
 Normal (100/60–140/90) 14 (67%)
 High (>140/90) 6 (29%)
Functional status (BI)
 Independency/slightly dependency (BI 95–100) 2 (10%)
 Moderate dependency (BI 65–90) 3 (14%)
 Severe dependency (BI 25–60) 7 (33%)
 Total dependency (BI 0–20) 9 (43%)
Secondary prevention
 Acetylsalicylic acid 11 (52%)
 Antihypertensive drug 9 (43%)
 Warfarin 0
 Non-vitamin K dependent oral anticoagulant drug 0
 No 9 (43%)
  1. BI Barthel Index, mRS modified Rankin Scale